References
- Anderson GD, Lynn AM. Optimizing pediatric dosing: a developmental pharmacologic approach. Pharmacbookapy. 2009;29:680–690.
- Anderson GD. Children versus adults: pharmacokinetic and adverse-effect differences. Epilepsia. 2002;43:53–59.
- Blanca Sánchez M, Herranz JL, Leno C, et al. UGT2B7-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study. Ther Drug Monit. 2010;32:177–184.
- Chaudhary N, Kabra M, Gulati S, et al. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy. BMC Pediatr. 2016;1:66.
- Guo Y, Hu C, He X, et al. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy. Drug Metab Pharmacokinet. 2012;27:536–542.
- Goto S, Seo T, Murata T, et al. Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese. Ther Drug Monit. 2007;29:118–121.
- Saruwatari J, Ishitsu T, Seo T, et al. The clinical impact of cytochrome P450 polymorphisms on the anti-epileptic drug therapy. Pharmaceuticals (Basel). 2010;3:2709–2732.
- Mahringer A, Fricker G. ABC transporters at the blood-brain barrier. Expert Opin Drug Metab Toxicol. 2016;12:499–508.
- Galovic M, Koepp M. Advances of molecular imaging in epilepsy. Curr Neurol Neurosci Rep. 2016;16:58.
- Feldmann M, Asselin MC, Liu J, et al. P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study. Lancet. 2013;12:777–785.
- Li S-X, Liu -Y-Y, Wang Q-B. ABCB1 Gene C3435T polymorphism and drug resistance in epilepsy: evidence based on 8604 subjects. Med Sci Monit. 2015;21:861–868.
- Emich-Widera E, Likus W, Kazek B, et al. Polymorphism of ABCB1/MDR1 C3435T in children and adolescents with partial epilepsy is due to different criteria for drug resistance – preliminary results. Med Sci Monit. 2014;20:1654–1661.
- Wang P, Yin T, Ma HY, et al. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Epilepsy Res. 2015;117:52–57.
- Zhou Y, Wang X, Li H, et al. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients. Drug Metab Pharmacokinet. 2015;30:282–287.
- Zhang C, Zuo Z, Kwan P, et al. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein. Epilepsia. 2011;52:1894–1904.